US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about Clinical Study Initiation

Recent news which mentions Clinical Study Initiation

Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate
Tickers AGEN
Tags Small Cap General AGEN
From Benzinga
KalVista Shares Climb As Late-Stage Label Extension Study On Skin Disorder Candidate Kicks-off
Tickers KALV
Tags Movers & Shakers Small Cap General
From Benzinga
ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off
Tickers ALXO LLY MRK
Tags Biotech Market News Health Care
From Benzinga
Pfizer And Valneva Commence Late-Stage Lyme Disease Study
Tickers PFE VALN
Tags Health Care Market News Biotech
From Benzinga
Astria Therapeutics Commences Initial-Stage Skin Disorder Study, Sees Preliminary Data By Year-end
Tickers ATXS
Tags Market News Penny Stocks Biotech
From Benzinga
MediciNova Commences Mid-Stage Non-alcoholic Fatty Liver Disease Study
Tickers MNOV
Tags Benzinga General Clinical Study Initiation
From Benzinga
Aligos Shares Fall Following Commencement Of Initial-Stage Chronic Hepatitis B Study
Tickers ALGS
Tags Clinical Study Initiation ALGS Health Care
From Benzinga
Aytu BioPharma Commences Late-Stage Genetic Disorder Study
Tickers AYTU
Tags AYTU Biotech Penny Stocks
From Benzinga
Edgewise Therapeutics Initiates Mid-Stage Muscular Dystrophies Study
Tickers EWTX
Tags General Small Cap EWTX
From Benzinga
Corcept Therapeutics Commences Late-Stage Ovarian Cancer Study
Tickers CORT
Tags Benzinga General Clinical Study Initiation
From Benzinga
Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection
Tickers ASMB
Tags General Benzinga Biotech
From Benzinga